Literature DB >> 23544009

Considerations in the initial management of follicular lymphoma.

Loretta Nastoupil1, Rajni Sinha, Auldyn Hirschey, Christopher R Flowers.   

Abstract

Entities:  

Year:  2012        PMID： 23544009      PMCID： PMC3610920          DOI： 10.1016/j.cmonc.2012.09.015

Source DB:  PubMed          Journal:  Community Oncol        ISSN： 1548-5315


× No keyword cloud information.
  48 in total

1.  Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Dreyling
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

Review 3.  Staging non-Hodgkin lymphoma.

Authors:  James O Armitage
Journal:  CA Cancer J Clin       Date:  2005 Nov-Dec       Impact factor: 508.702

4.  CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.

Authors:  Robert Marcus; Kevin Imrie; Andrew Belch; David Cunningham; Eduardo Flores; John Catalano; Philippe Solal-Celigny; Fritz Offner; Jan Walewski; Joäo Raposo; Andrew Jack; Paul Smith
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

Review 5.  Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful?

Authors:  Ph Solal-Céligny; X Cahu; G Cartron
Journal:  Int J Hematol       Date:  2010-08-31       Impact factor: 2.490

Review 6.  The clinical course of follicular lymphoma.

Authors:  Ama Z S Rohatiner; T Andrew Lister
Journal:  Best Pract Res Clin Haematol       Date:  2005-03       Impact factor: 3.020

Review 7.  Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review.

Authors:  G Damaj; V Verkarre; A Delmer; P Solal-Celigny; I Yakoub-Agha; C Cellier; F Maurschhauser; R Bouabdallah; V Leblond; F Lefrère; D Bouscary; J Audouin; B Coiffier; B Varet; T Molina; N Brousse; O Hermine
Journal:  Ann Oncol       Date:  2003-04       Impact factor: 32.976

8.  Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.

Authors:  Michele Ghielmini; Shu-Fang Hsu Schmitz; Sergio B Cogliatti; Gabriella Pichert; Jörg Hummerjohann; Ursula Waltzer; Martin F Fey; Daniel C Betticher; Giovanni Martinelli; Fedro Peccatori; Urs Hess; Emanuele Zucca; Roger Stupp; Tibor Kovacsovics; Claudine Helg; Andreas Lohri; Mario Bargetzi; Daniel Vorobiof; Thomas Cerny
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

9.  Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.

Authors:  Jonathan W Friedberg; Michelle Byrtek; Brian K Link; Christopher Flowers; Michael Taylor; John Hainsworth; James R Cerhan; Andrew D Zelenetz; Jamie Hirata; Thomas P Miller
Journal:  J Clin Oncol       Date:  2012-08-20       Impact factor: 44.544

10.  Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.

Authors:  Ranjana Advani; Saul A Rosenberg; Sandra J Horning
Journal:  J Clin Oncol       Date:  2004-03-15       Impact factor: 44.544
View more
  2 in total

Review 1.  Follicular Lymphoma: Past, Present, and Future.

Authors:  Melody R Becnel; Loretta J Nastoupil
Journal:  Curr Treat Options Oncol       Date:  2018-05-24

2.  Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate-High Risk: A Cost-Effectiveness Analysis.

Authors:  Marco Bellone; Lorenzo Pradelli; Stefano Molica; Adele Emanuela De Francesco; Daniela Ghislieri; Emanuele Guardalben; Antonietta Caputo
Journal:  Clinicoecon Outcomes Res       Date:  2021-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.